Pathstone Family Office’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Pathstone Family Office’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-170	Closed	-$20K	–	1473
2020 Q4	$20K	Hold	170	–	–	﹤0.01%	701
2020 Q3	$17K	Hold	170	–	–	﹤0.01%	518
2020 Q2	$21K	Hold	170	–	–	﹤0.01%	423
2020 Q1	$15K	Buy	+170	New	+$18K	﹤0.01%	459
2019 Q4	–	Sell	-170	Closed	-$20K	–	663
2019 Q3	$20K	Hold	170	–	–	﹤0.01%	395
2019 Q2	$29K	Buy	+170	New	+$29.4K	﹤0.01%	403

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pathstone Family Office's GWPH Position: Q1 2021 in Review

Pathstone Family Office sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 170 shares — an estimated $20K sold.

Pathstone Family Office first reported a position in GWPH in Q2 2019 and held it in 6 quarters. The position peaked at $29K in Q2 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Pathstone Family Office reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Pathstone Family Office sold 170 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $20K.
Pathstone Family Office first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 6 quarters.
Pathstone Family Office's GW Pharmaceuticals Plc American Depositary Shares position peaked at $29K in Q2 2019.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Pathstone Family Office's 13F filing for Q1 2021, filed 14 May 2021.